Nordic venture capital firms expand to listed biotechs in hunt for bargains
Large stock drops for listed biotech companies have piqued the interest of two Nordic investors, one of which is backed by Novo Holdings.
By Love Liman, bloomberg
Two Nordic early-stage biotech investors are warming to the idea of buying into listed companies that have become too cheap to ignore.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Holdings eyes opportunities as biotech bubble bursts
For subscribers
